Precipio (PRPO) Stock: Buy, Sell, or Hold?
PRPO - Precipio, Inc. Common Stock
$27.32
0.41 (1.52%)
â˛
5d:
+4.59%
30d:
+21.21%
90d:
+20.72%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 17, 2026
0d
Get Alerted When PRPO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: PRPO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: PRPO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: PRPO is currently trading at $27.32, which is considered fair relative to its 30-day fair value range of $23.57 to $29.16.
Technical Outlook: Technically, PRPO is showing sideways momentum. Immediate support is located at $24.48, while resistance sits at $30.55.
Market Sentiment: PRPO scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $19.00. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PRPO is showing sideways momentum. Immediate support is located at $24.48, while resistance sits at $30.55.
Market Sentiment: PRPO scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $19.00. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$23.57 -
$29.16
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
39.5%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 30.5% above Wall St target ($19.00)
- WARNING: Composite score 41/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$23.57 -
$29.16
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$24.48
Resistance Level
$30.55
Current Trend
Sideways
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.43
Wall Street Target
$19.00
(-30.5%)
Revenue Growth (YoY)
24.2%
Profit Margin
-4.5%
Share & Embed Analysis
Last updated: September 12, 2026 12:10 AM ET
Data refreshes hourly during market hours. Next update: 1:10 AM
Data refreshes hourly during market hours. Next update: 1:10 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRPO showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Ahmed Zaki Sabet
BUY
19 shares
2026-04-01
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher ScientificâĻ |
STRONG BUY
31 analysts |
$638 | 51 HOLD |
|
EXAS
EXACT Sciences CorporatiâĻ |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$229 | 49 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$194 | 49 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$338 | 47 HOLD |
